Boston Scientific Cardiology
@bsccardiology.bsky.social
Boston Scientific Cardiology. We invite physicians in the U.S. to learn about our cardiology & electrophysiology therapies and devices. http://bit.ly/2cOqgdl
See Dr. Bernabei's first case using contact sensing on the FARAVIEW™ Software Module. After 3 RF procedures that resulted in reconnection, Dr. Bernabei and the team at Lancaster General Hospital successfully ablated the PVs and PW using FARAWAVE™ NAV PFA Catheter.
#PFAonFARAVIEW
#PFAonFARAVIEW
December 17, 2025 at 8:20 PM
See Dr. Bernabei's first case using contact sensing on the FARAVIEW™ Software Module. After 3 RF procedures that resulted in reconnection, Dr. Bernabei and the team at Lancaster General Hospital successfully ablated the PVs and PW using FARAWAVE™ NAV PFA Catheter.
#PFAonFARAVIEW
#PFAonFARAVIEW
Why did we choose paclitaxel for our AGENT™ DCB design? For higher drug transfer. Learn more: qrco.de/bgUugT
AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1
AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1
December 16, 2025 at 4:31 PM
Why did we choose paclitaxel for our AGENT™ DCB design? For higher drug transfer. Learn more: qrco.de/bgUugT
AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1
AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1
COMING SOON: The FARAPULSE™ PFA Platform will be expanding to include the FARAPOINT™ PFA Catheter, upon FDA approval, a NAV-enabled PFA optimized catheter designed to create both focal and linear-shaped lesions. Prepare to enhance your PFA workflow with FARAPOINT. See how it works: qrco.de/bgVhhC
December 15, 2025 at 5:39 PM
COMING SOON: The FARAPULSE™ PFA Platform will be expanding to include the FARAPOINT™ PFA Catheter, upon FDA approval, a NAV-enabled PFA optimized catheter designed to create both focal and linear-shaped lesions. Prepare to enhance your PFA workflow with FARAPOINT. See how it works: qrco.de/bgVhhC
“For the first time we’ve got clinical data about #PFA in right atrial lesion sets...We demonstrated that there were no safety events, no coronary spasm..., no hemolysis related directly to the FARAPOINT™ Catheter, and high clinical success.”
See the data: qrco.de/bgVg1g
#Epeeps
See the data: qrco.de/bgVg1g
#Epeeps
December 8, 2025 at 5:17 PM
“For the first time we’ve got clinical data about #PFA in right atrial lesion sets...We demonstrated that there were no safety events, no coronary spasm..., no hemolysis related directly to the FARAPOINT™ Catheter, and high clinical success.”
See the data: qrco.de/bgVg1g
#Epeeps
See the data: qrco.de/bgVg1g
#Epeeps
In a recent case, FARAVIEW™ Software Module displayed how contact sensing and FIELDTAG™ Technology enhance procedural confidence. Physicians can visualize catheter contact information and rotation, supporting an optimized PFA workflow.
Learn more: qrco.de/bgTyY7
#PFAonFARAVIEW
Learn more: qrco.de/bgTyY7
#PFAonFARAVIEW
December 1, 2025 at 4:12 PM
In a recent case, FARAVIEW™ Software Module displayed how contact sensing and FIELDTAG™ Technology enhance procedural confidence. Physicians can visualize catheter contact information and rotation, supporting an optimized PFA workflow.
Learn more: qrco.de/bgTyY7
#PFAonFARAVIEW
Learn more: qrco.de/bgTyY7
#PFAonFARAVIEW
We’ve reimagined what’s possible for #PFA — a fully integrated future that’s driving innovation and shaping what’s next. The FARAPULSE™ PFA Platform is a transformative leap forward. Built for the EP lab, it provides tools from transseptal access to ablation to real-time mapping.
November 26, 2025 at 2:30 PM
We’ve reimagined what’s possible for #PFA — a fully integrated future that’s driving innovation and shaping what’s next. The FARAPULSE™ PFA Platform is a transformative leap forward. Built for the EP lab, it provides tools from transseptal access to ablation to real-time mapping.
#LAAC Case Highlight: Dr. Asad Cheema, Englewood Hospital & Medical Center, used the WATCHMAN TruSteer™ Access System to navigate this challenging anterior chicken wing appendage with prominent pectinate. He then successfully deployed the WATCHMAN FLX™ Pro Device, achieving complete closure.
November 24, 2025 at 2:00 PM
#LAAC Case Highlight: Dr. Asad Cheema, Englewood Hospital & Medical Center, used the WATCHMAN TruSteer™ Access System to navigate this challenging anterior chicken wing appendage with prominent pectinate. He then successfully deployed the WATCHMAN FLX™ Pro Device, achieving complete closure.
Join us Dec. 5–7, in Washington, D.C. cvent.me/2a5BYn
TransformAF EP Fellows Experience 2025 delivers immersive learning on the FARAPULSE™ PFA Platform and WATCHMAN FLX™ Pro LAAC Device, with case-based insights, panel discussions, & practical tips you can bring back to your practice. #EPeeps
TransformAF EP Fellows Experience 2025 delivers immersive learning on the FARAPULSE™ PFA Platform and WATCHMAN FLX™ Pro LAAC Device, with case-based insights, panel discussions, & practical tips you can bring back to your practice. #EPeeps
November 19, 2025 at 8:52 PM
Join us Dec. 5–7, in Washington, D.C. cvent.me/2a5BYn
TransformAF EP Fellows Experience 2025 delivers immersive learning on the FARAPULSE™ PFA Platform and WATCHMAN FLX™ Pro LAAC Device, with case-based insights, panel discussions, & practical tips you can bring back to your practice. #EPeeps
TransformAF EP Fellows Experience 2025 delivers immersive learning on the FARAPULSE™ PFA Platform and WATCHMAN FLX™ Pro LAAC Device, with case-based insights, panel discussions, & practical tips you can bring back to your practice. #EPeeps
See how imaging + vessel prep drive success in PCI with AGENT™ DCB. Top interventional cardiologists walk through key clinical cases. 🎥View the full case on EDUCARE: qrco.de/bgHo7U
AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1
AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1
November 17, 2025 at 1:30 PM
See how imaging + vessel prep drive success in PCI with AGENT™ DCB. Top interventional cardiologists walk through key clinical cases. 🎥View the full case on EDUCARE: qrco.de/bgHo7U
AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1
AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1
Boston Scientific is partnering with Siemens Healthineers on the workflow development and commercialization of a next-gen ACUNAV 4D ICE catheter designed to enable guidance from the right atrium, streamline workflows and simplify procedures. (1/2)
November 13, 2025 at 10:18 PM
Boston Scientific is partnering with Siemens Healthineers on the workflow development and commercialization of a next-gen ACUNAV 4D ICE catheter designed to enable guidance from the right atrium, streamline workflows and simplify procedures. (1/2)
OPTIMIZE has begun!
November 12, 2025 at 3:38 PM
OPTIMIZE has begun!
Discover how UCHealth’s concomitant #PFA & #LAAC procedural approach is setting a new standard in AF management. Join us for a discussion on launching a concomitant practice, where clinicians share practical advice, unexpected challenges, and transformative impacts on AFib care & patient outcomes.
November 7, 2025 at 7:35 PM
Transforming PCI with #IVUS! Discover how it enhances patient outcomes and leads to higher long-term survival rates. 🔗 Explore our clinical data: qrco.de/bgI5uw
November 6, 2025 at 1:30 PM
Transforming PCI with #IVUS! Discover how it enhances patient outcomes and leads to higher long-term survival rates. 🔗 Explore our clinical data: qrco.de/bgI5uw
Why do atrial arrhythmia (AA) burden and AA episode duration matter? 💭
In the ADVANTAGE AF Phase II trial, the LUX-Dx™ Insertable Cardiac Monitor Systems (ICM) measured AA burden and longest AA episode duration—two powerful predictors of clinical success and healthcare utilization:
In the ADVANTAGE AF Phase II trial, the LUX-Dx™ Insertable Cardiac Monitor Systems (ICM) measured AA burden and longest AA episode duration—two powerful predictors of clinical success and healthcare utilization:
November 5, 2025 at 2:38 PM
Why do atrial arrhythmia (AA) burden and AA episode duration matter? 💭
In the ADVANTAGE AF Phase II trial, the LUX-Dx™ Insertable Cardiac Monitor Systems (ICM) measured AA burden and longest AA episode duration—two powerful predictors of clinical success and healthcare utilization:
In the ADVANTAGE AF Phase II trial, the LUX-Dx™ Insertable Cardiac Monitor Systems (ICM) measured AA burden and longest AA episode duration—two powerful predictors of clinical success and healthcare utilization:
The LUX-Dx II+ AT algorithm can detect Atrial Tachycardia, Atrial Flutter, Atrial Fibrillation, sinus tachycardia or any other rhythms without compromising the AF algorithm’s detection performance. Learn more: qrco.de/bgFrUP
Safety info: qrco.de/bfqd4c
Safety info: qrco.de/bfqd4c
November 4, 2025 at 1:30 PM
The LUX-Dx II+ AT algorithm can detect Atrial Tachycardia, Atrial Flutter, Atrial Fibrillation, sinus tachycardia or any other rhythms without compromising the AF algorithm’s detection performance. Learn more: qrco.de/bgFrUP
Safety info: qrco.de/bfqd4c
Safety info: qrco.de/bfqd4c
What does modern PCI look like with AGENT™ DCB? 🎥Watch expert-led case studies showcasing the importance of imaging and vessel prep in DCB cases. EDUCARE has the full story: ttps://qrco.de/bgHnu0
AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1
AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1
November 3, 2025 at 1:30 PM
What does modern PCI look like with AGENT™ DCB? 🎥Watch expert-led case studies showcasing the importance of imaging and vessel prep in DCB cases. EDUCARE has the full story: ttps://qrco.de/bgHnu0
AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1
AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1
📊 Just in from #TCT2025! In the SHORT-CUT trial, WOLVERINE™ Cutting Balloon was noninferior to intravascular lithotripsy (IVL) for post-PCI MSA at site of max calcium and cut total procedural cost by $3,632 ($9,409 vs $13,051; p < 0.001).
October 31, 2025 at 2:12 PM
📊 Just in from #TCT2025! In the SHORT-CUT trial, WOLVERINE™ Cutting Balloon was noninferior to intravascular lithotripsy (IVL) for post-PCI MSA at site of max calcium and cut total procedural cost by $3,632 ($9,409 vs $13,051; p < 0.001).
How are you helping your patients manage their stroke risk? Join us in supporting advancements in #stroke protection this #WorldStrokeDay. SENTINEL™ CPS and WATCHMAN™ #LAAC Device, are designed to reduce stroke risks and enhance the quality of patient care.
October 29, 2025 at 5:00 PM
How are you helping your patients manage their stroke risk? Join us in supporting advancements in #stroke protection this #WorldStrokeDay. SENTINEL™ CPS and WATCHMAN™ #LAAC Device, are designed to reduce stroke risks and enhance the quality of patient care.
New Data from #TCT2025: The OPTION Cost-Effectiveness Analysis showed that the WATCHMAN FLX™ #LAAC Device is a cost-saving and health-improving alternative to OAC alone in post-ablation patients with non-valvular #AFib.
View the full OPTION Clinical Trial results here: qrco.de/bgPnPH
View the full OPTION Clinical Trial results here: qrco.de/bgPnPH
October 29, 2025 at 1:42 PM
New Data from #TCT2025: The OPTION Cost-Effectiveness Analysis showed that the WATCHMAN FLX™ #LAAC Device is a cost-saving and health-improving alternative to OAC alone in post-ablation patients with non-valvular #AFib.
View the full OPTION Clinical Trial results here: qrco.de/bgPnPH
View the full OPTION Clinical Trial results here: qrco.de/bgPnPH
We want to extend a big thank you to our IC community for an incredible #TCT2025. Through hands-on training and cross-team collaboration, your passion continues to advance interventional cardiology and the patient care continuum. We can’t wait to see you next year at #TCT2026!
October 28, 2025 at 11:30 PM
Just in from #TCT2025: In the ALLIANCE registry, an all-comers de novo registry with over 1,800 patients, Paclitaxel DCBs including AGENTTM DCB (73.3%) and SeQuent® Please NEO (26.4%) met the primary endpoint with a 1-year TLF rate of 4.7% for complex and varied de novo lesions. qrco.de/bgPp9K
October 27, 2025 at 9:26 PM
Just in from #TCT2025: In the ALLIANCE registry, an all-comers de novo registry with over 1,800 patients, Paclitaxel DCBs including AGENTTM DCB (73.3%) and SeQuent® Please NEO (26.4%) met the primary endpoint with a 1-year TLF rate of 4.7% for complex and varied de novo lesions. qrco.de/bgPp9K
Happening now at #TCT2025: educational sessions on ISR treatment, #LAAC, renal denervation, and more at Hub #1. Join us today through Tuesday!
See the schedule of events: spklr.io/63329BKIe3
See the schedule of events: spklr.io/63329BKIe3
October 26, 2025 at 3:00 PM
Happening now at #TCT2025: educational sessions on ISR treatment, #LAAC, renal denervation, and more at Hub #1. Join us today through Tuesday!
See the schedule of events: spklr.io/63329BKIe3
See the schedule of events: spklr.io/63329BKIe3
Don’t forget to stop by Hub #1 and Innovation Drive for hands-on training with the latest Boston Scientific tools and technologies during your time at #TCT2025.
Visit our page for a full schedule of events: qrco.de/bgMdGS
Visit our page for a full schedule of events: qrco.de/bgMdGS
October 26, 2025 at 2:30 PM
Don’t forget to stop by Hub #1 and Innovation Drive for hands-on training with the latest Boston Scientific tools and technologies during your time at #TCT2025.
Visit our page for a full schedule of events: qrco.de/bgMdGS
Visit our page for a full schedule of events: qrco.de/bgMdGS
Hear the latest highlighted clinical data that could redefine patient care at #TCT2025. Don’t just hear the future, witness it with industry-leading experts and your peers.
View our schedule of events and data here: spklr.io/63324BKIer
View our schedule of events and data here: spklr.io/63324BKIer
October 25, 2025 at 3:00 PM
Hear the latest highlighted clinical data that could redefine patient care at #TCT2025. Don’t just hear the future, witness it with industry-leading experts and your peers.
View our schedule of events and data here: spklr.io/63324BKIer
View our schedule of events and data here: spklr.io/63324BKIer